Venus Medtech (Hangzhou) Inc

02500

Company Profile

  • Business description

    Venus Medtech (Hangzhou) Inc is engaged in the development and commercialization of transcatheter solutions for structural heart diseases. It has two TAVR products on the market, namely VenusA-Valve, and VenusA-Plus. VenusA-Valve is its first-generation TAVR device, which is used to treat severe Aortic Stenosis (AS) using a transcatheter approach. VenusA-Plus is an upgraded product of VenusA-Valve. Geographically majority of the revenue is derived from Mainland China.

  • Contact

    No. 88, Jiangling Road
    Room 311, 3rd Floor, Block 2
    Binjiang District
    Hangzhou310051
    CHN

    T: +86 57187772180

    https://www.venusmedtech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    605

Stocks News & Analysis

stocks

What does big US court decision mean for Google’s parent company Alphabet?

Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.
stocks

Our only 5-star wide moat ASX share

A difficult year but better times ahead.
stocks

Is this still an ASX share to own forever?

Find out how this defensive player has fared after earnings.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,140.5011.000.12%
CAC 407,656.1042.82-0.56%
DAX 4023,625.66144.67-0.61%
Dow JONES (US)45,316.53304.76-0.67%
FTSE 1009,204.9811.89-0.13%
HKSE25,417.98359.471.43%
NASDAQ21,621.7185.98-0.40%
Nikkei 22543,018.75438.481.03%
NZX 50 Index13,223.5390.330.69%
S&P 5006,464.5837.50-0.58%
S&P/ASX 2008,871.208.600.10%
SSE Composite Index3,812.5146.641.24%

Market Movers